Furthermore, through YTHDF2-dependent post-transcriptional silencing of suppressor of cytokine signaling (SOCS2), METTL3 was discovered to serve a pro-oncogenic role in human HCC by increasing proliferation and metastasis (49). Here, METTL3 is linked to hepatocellular carcinoma.